Monday, June 15, 2026
6:15 PM – 6:30 PM: Registration and Dinner
6:30 PM – 8:00 PM: Symposium
Hilton Baltimore Inner Harbor
401 W. Pratt Street
Baltimore, Maryland 21201
Meeting Room: Key Ballroom, 5-6
PROGRAM FEATURES
- Interactive, case-based learning environment
- Create your own personalized poster
- Downloadable HD Animation
- Live patient perspectives
PRESENTING FACULTY
 |
Richard Schwab, MD Professor, Department of Medicine Chief, Division of Sleep Medicine University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania |
 |
Charles Bae, MD, MHCI, FAASM Associate CHIO for Connected Health Strategy Associate Professor of Clinical Medicine and Neurology University of Pennsylvania Perelman School of Medicine Associate Chief of Informatics Penn Sleep Center Philadelphia, Pennsylvania |
PATIENT PERSPECTIVE
 |
Andrea Brooks, MSW, LSW Lifeline Connections President and CEO Vancouver, Washington |
PROGRAM OVERVIEW
This CME program, developed for sleep medicine clinicians, focuses on improving the timely and accurate diagnosis of narcolepsy type 1 (NT1). Learners will strengthen their ability to apply AASM diagnostic criteria together with clinical history, polysomnography (PSG), and multiple sleep latency testing (MSLT) data to reduce misdiagnosis and shorten the time to NT1 identification. The program also equips clinicians to overcome referral barriers and integrate evidence on current and emerging narcolepsy therapies to optimize individualized treatment selection.
TARGET AUDIENCE
This activity is designed to meet the educational needs of healthcare providers certified in sleep medicine, such as neurologists, psychiatrists, pulmonologists, and primary care physicians.
LEARNING OBJECTIVES
- Integrate AASM diagnostic criteria and clinical history, PSG, and MSLT findings to reduce misdiagnosis and shorten time to NT1 diagnosis
- Implement strategies to overcome barriers to timely diagnosis and referral for NT1
- Apply clinical data for current and emerging therapies for narcolepsy to optimize individualized treatment selection
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.
AAPA CREDIT DESIGNATION STATEMENT – Live
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ACCME INNOVATION PARTNER – US Learners Only
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
